Search
Testosterone cypionate
go.drugbank.com/drugs/DB13943ApprovedInvestigationalTestosterone cypionate is a synthetic derivative of testosterone in the form of an oil-soluble 17 (beta)-cyclopentylpropionate ester. … It was developed by the company Pharmacia and Upjohn and FDA approved on July 25, 1979.
Categories: P-glycoprotein inhibitors, Cytochrome P-450 SubstratesProducts: .- Im 100mg/ml, Depo-testosterone Inj 100mg/mlSea salt
go.drugbank.com/drugs/DB11266ApprovedIn comparison, table salt is mined from underground sedimentary deposits and is more heavily processed to eliminate minerals. … Sea salt is a food ingredient and is often colored by adding charcoal or red clay to sometimes be referred to as “Hawaiian Sea Salt.”
Products: S Panax All In One Liquidsoap, S Panax LiquidsoapIopamidol
go.drugbank.com/drugs/DB08947ApprovedInvestigationalIopamidol is a contrast agent developed by Bracco with nonionic, low-osmolar properties.
Categories: Compounds used in a research, industrial, or household setting, Diagnostic Uses of ChemicalsProducts: Isovue 370 Inj 76%, Isovue 200 Inj 41%Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
go.drugbank.com/bio_entities/BE0001080TargetHumansInvolved in bitter and sweet taste transduction as well as in umami (monosodium glutamate, monopotassium glutamate, and inosine monophosphate) taste transduction (PubMed:40339580, PubMed:38600377, PubMed … Guanine nucleotide-binding proteins (G proteins) are involved as a modulator or transducer in various transmembrane signaling systems (PubMed:29925951, PubMed:33762731, PubMed:34239069, PubMed:35610220
Polypeptides: Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2Fluphenazine
go.drugbank.com/drugs/DB00623ApprovedA phenothiazine used in the treatment of psychoses. Its properties and uses are generally similar to those of chlorpromazine.
Categories: Dopamine D2 Receptor Antagonists, P-glycoprotein inhibitorsSynonyms: 1-(2-hydroxyethyl)-4-(3-(trifluoromethyl-10-phenothiazinyl)propyl)-piperazine, 10-(3'-(4''-(β-hydroxyethyl)-1''-piperazinyl)-propyl)-3-trifluoromethylphenothiazineSodium fluoride
go.drugbank.com/drugs/DB09325ApprovedInvestigationalThe use of fluoride in dental practice began in the 1940s. … and is highly effective in reducing the prevalence of caries.
Mixtures: Exoden All In One, Colgate Total Clean in BetweenCategories: Compounds used in a research, industrial, or household settingEzetimibe
go.drugbank.com/drugs/DB00973ApprovedInvestigationalThe discovery and research of this drug began in the early 1990s, after the intravenous administration of radiolabelled ezetimibe in rats revealed that it was being localized within enterocytes of the … [A33313] In genetically NPC1L1-deficient mice, a 70% reduction in intestinal cholesterol absorption was seen, and these mice were insensitive to ezetimibe treatment - it was determined based on these findings
Mixtures: EZETIMIBE E SIMVASTATINA DOC GENERICI, EZETIMIBE E SIMVASTATINA DOC GENERICICategories: P-glycoprotein substrates, Cytochrome P-450 CYP2C8 InhibitorsRacementhol
go.drugbank.com/drugs/DB14123ApprovedInvestigationalMixtures: Marcs Original, Marcs Blue MintSynonyms: p-Menthan-3-ol, DL-mentholGonadorelin
go.drugbank.com/drugs/DB00644ApprovedInvestigationalVet approvedGonadorelin is another name for gonadotropin-releasing hormone (GnRH). It is a synthetic decapeptide prepared using solid phase peptide synthesis. … GnRH is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pituitary.
Mixtures: Relisorm 500 for Inj.-pws Liq-kit IV Sc, Relisorm 100 for Inj.-pws Liq-kit Sc IVProducts: LH-RH FERRING 0,1 MG/ML IV ENJEKSIYONLUK COZELTI ICEREN AMPUL, 1 ADET, Factrel Inj 0.5mg/vialPosaconazole
go.drugbank.com/drugs/DB01263ApprovedInvestigationalVet approvedPosaconazole is a triazole antifungal drug that is used to treat invasive infections by Candida species and Aspergillus species in severely immunocompromised patients.
Categories: Metabolic Side Effects of Drugs and Substances, P-glycoprotein inhibitorsProducts: POSIOLE® IV SOLUCIÓN PARA INFUSIÓN 300 MG/16.7 ML, NOXAFIL ® TABLETAS RECUBIERTAS DE LIBERACIÓN RETARDADA